Clinical Trial Supply Europe 2018
‘Developing best practices and incorporating novel technologies to meet the demand of more complex, international clinical trial supply’
CTS Europe will be returning for the 19th edition next March. This prestigious event will welcome representatives from 6 of the top 10 pharmaceutical companies in Europe, who will be joined by leading biotech companies across the continent to jointly find solutions for your clinical trial supply problems and discuss changes in the industry.
As a streamed event this conference promises to address a larger variety of topics, with sessions covering all the essentials in clinical supply, from maximising forecasting software to patient centric strategies for supply chain and considering methods to achieve last mile delivery.
2018 Agenda Highlights:
- Workshop: Assessing value in e-label technology to expedite packaging and labelling timeliness
- Unpacking how patient centricity will change the clinical supply chain and how to prepare for this
- Debate: Determining the value of building internal IRT systems vs purchasing ‘off the shelf’
- Digitalizing clinical manufacturing; reducing waste, minimize human error and improving efficiency
- Exploring various comparator sourcing models to determine which is most cost effective and cases least disruption to your supply
2018 Key Speakers:
- Jan-Pieter Kappelle, Senior Director, Clinical Trial Supplies, UCB
- Henk Mollee, Senior Director, CTM Manufacturing, Astellas Pharmaceuticals
- Niklas Mattsson, Lead Comparator Sourcing and Planning, MSD
- Alison Meyers, Director Clinical Liaison Lead, Clinical Interface, GlaxoSmithKline
- Ross MacRae, Senior Director Clinical Manufacturing, Pfizer
- Erik Meyer, Director Clinical Trial Supply, Merck
- Peter Orosz, Head of Clinical Supply Chain Management & Oncology, Boehringer Ingelheim
- Alex Robertson, Senior Director, Supply Chain Management, AstraZeneca
